J Lobo, AJM Gillis, A van den Berg,
LHJ Looijenga - BMC cancer, 2020 - Springer
Background Better biomarkers for assessing risk of relapse in stage I testicular germ cell
tumor patients are needed, to complement classical histopathological variables. We aimed …